Literature DB >> 15044018

The islet-specific glucose-6-phosphatase-related protein, implicated in diabetes, is a glycoprotein embedded in the endoplasmic reticulum membrane.

Jeng-Jer Shieh1, Chi-Jiunn Pan, Brian C Mansfield, Janice Yang Chou.   

Abstract

The islet-specific glucose-6-phosphatase-related protein (IGRP) has no known catalytic activity, but is of interest because it is the source of the peptide autoantigen targeted by a prevalent population of pathogenic CD8(+) T cells in non-obese diabetic mice. To better understand the potential roles of this protein in diabetes mellitus, we examine the subcellular localization and membrane topography of human IGRP. We show that IGRP is a glycoprotein, held in the endoplasmic reticulum by nine transmembrane domains, which is degraded in cells predominantly through the proteasome pathway that generates the major histocompatibility complex class I-presented peptides.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15044018     DOI: 10.1016/S0014-5793(04)00223-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  7 in total

1.  In islet-specific glucose-6-phosphatase-related protein, the beta cell antigenic sequence that is targeted in diabetes is not responsible for the loss of phosphohydrolase activity.

Authors:  J-J Shieh; C-J Pan; B C Mansfield; J Y Chou
Journal:  Diabetologia       Date:  2005-07-13       Impact factor: 10.122

2.  A variant in the G6PC2/ABCB11 locus is associated with increased fasting plasma glucose, increased basal hepatic glucose production and increased insulin release after oral and intravenous glucose loads.

Authors:  C S Rose; N Grarup; N T Krarup; P Poulsen; L Wegner; T Nielsen; K Banasik; K Faerch; G Andersen; A Albrechtsen; K Borch-Johnsen; J O Clausen; T Jørgensen; A Vaag; O Pedersen; T Hansen
Journal:  Diabetologia       Date:  2009-08-08       Impact factor: 10.122

3.  Distribution patterns of calcium-binding proteins in pancreatic tissue of non-diabetic as well as type 2 diabetic rats and in rat insulinoma beta-cells (INS-1).

Authors:  Ivonne Bazwinsky-Wutschke; Sabine Wolgast; Eckhard Mühlbauer; Elmar Peschke
Journal:  Histochem Cell Biol       Date:  2010-07-07       Impact factor: 4.304

Review 4.  Glucose-6-phosphatase catalytic subunit gene family.

Authors:  John C Hutton; Richard M O'Brien
Journal:  J Biol Chem       Date:  2009-08-20       Impact factor: 5.157

5.  Mapping I-A(g7) restricted epitopes in murine G6PC2.

Authors:  Tao Yang; Anita C Hohenstein; Catherine E Lee; John C Hutton; Howard W Davidson
Journal:  Immunol Res       Date:  2013-03       Impact factor: 2.829

6.  Alternative splicing and differential expression of the islet autoantigen IGRP between pancreas and thymus contributes to immunogenicity of pancreatic islets but not diabetogenicity in humans.

Authors:  V Martijn de Jong; Joana R F Abreu; Annemarie A Verrijn Stuart; Arno R van der Slik; Katrijn Verhaeghen; Marten A Engelse; Bianca Blom; Frank J T Staal; Frans K Gorus; Bart O Roep
Journal:  Diabetologia       Date:  2013-09-13       Impact factor: 10.122

7.  Variations in the G6PC2/ABCB11 genomic region are associated with fasting glucose levels.

Authors:  Wei-Min Chen; Michael R Erdos; Anne U Jackson; Richa Saxena; Serena Sanna; Kristi D Silver; Nicholas J Timpson; Torben Hansen; Marco Orrù; Maria Grazia Piras; Lori L Bonnycastle; Cristen J Willer; Valeriya Lyssenko; Haiqing Shen; Johanna Kuusisto; Shah Ebrahim; Natascia Sestu; William L Duren; Maria Cristina Spada; Heather M Stringham; Laura J Scott; Nazario Olla; Amy J Swift; Samer Najjar; Braxton D Mitchell; Debbie A Lawlor; George Davey Smith; Yoav Ben-Shlomo; Gitte Andersen; Knut Borch-Johnsen; Torben Jørgensen; Jouko Saramies; Timo T Valle; Thomas A Buchanan; Alan R Shuldiner; Edward Lakatta; Richard N Bergman; Manuela Uda; Jaakko Tuomilehto; Oluf Pedersen; Antonio Cao; Leif Groop; Karen L Mohlke; Markku Laakso; David Schlessinger; Francis S Collins; David Altshuler; Gonçalo R Abecasis; Michael Boehnke; Angelo Scuteri; Richard M Watanabe
Journal:  J Clin Invest       Date:  2008-07       Impact factor: 14.808

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.